CN102362950A - 一种治疗白癜风的中药 - Google Patents
一种治疗白癜风的中药 Download PDFInfo
- Publication number
- CN102362950A CN102362950A CN2011101698286A CN201110169828A CN102362950A CN 102362950 A CN102362950 A CN 102362950A CN 2011101698286 A CN2011101698286 A CN 2011101698286A CN 201110169828 A CN201110169828 A CN 201110169828A CN 102362950 A CN102362950 A CN 102362950A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- fructus
- chinese medicine
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 57
- 238000002360 preparation method Methods 0.000 claims abstract description 14
- 238000000034 method Methods 0.000 claims abstract description 12
- 210000000582 semen Anatomy 0.000 claims description 17
- 238000005516 engineering process Methods 0.000 claims description 12
- 229940079593 drug Drugs 0.000 claims description 11
- 241001446509 Psoralea Species 0.000 claims description 8
- 241000545442 Radix Species 0.000 claims description 8
- 239000000843 powder Substances 0.000 claims description 6
- 239000002775 capsule Substances 0.000 claims description 5
- 239000003826 tablet Substances 0.000 claims description 5
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 4
- 239000006187 pill Substances 0.000 claims description 4
- 239000002552 dosage form Substances 0.000 claims description 2
- 239000002674 ointment Substances 0.000 claims description 2
- -1 sublimed preparation Substances 0.000 claims description 2
- 241001421953 Eclipta <beetle> Species 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 29
- 239000008280 blood Substances 0.000 abstract description 25
- 210000004369 blood Anatomy 0.000 abstract description 24
- 210000004185 liver Anatomy 0.000 abstract description 22
- 210000003734 kidney Anatomy 0.000 abstract description 15
- 244000286838 Eclipta prostrata Species 0.000 abstract description 9
- 230000001105 regulatory effect Effects 0.000 abstract description 5
- 230000006870 function Effects 0.000 abstract description 3
- 230000004089 microcirculation Effects 0.000 abstract description 3
- 230000002265 prevention Effects 0.000 abstract description 3
- 230000008901 benefit Effects 0.000 abstract description 2
- 244000061520 Angelica archangelica Species 0.000 abstract 2
- 235000001287 Guettarda speciosa Nutrition 0.000 abstract 2
- 230000003213 activating effect Effects 0.000 abstract 2
- 241001061264 Astragalus Species 0.000 abstract 1
- 244000124209 Crocus sativus Species 0.000 abstract 1
- 235000015655 Crocus sativus Nutrition 0.000 abstract 1
- 241000244987 Daiswa polyphylla Species 0.000 abstract 1
- 241001289529 Fallopia multiflora Species 0.000 abstract 1
- 241000244355 Ligusticum Species 0.000 abstract 1
- 241000830535 Ligustrum lucidum Species 0.000 abstract 1
- 241001071917 Lithospermum Species 0.000 abstract 1
- 241001529733 Nepeta Species 0.000 abstract 1
- 241000304195 Salvia miltiorrhiza Species 0.000 abstract 1
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 abstract 1
- 241001180876 Saposhnikovia Species 0.000 abstract 1
- 241001521901 Tribulus lanuginosus Species 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 230000036039 immunity Effects 0.000 abstract 1
- 210000004233 talus Anatomy 0.000 abstract 1
- 238000010792 warming Methods 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 19
- 201000010099 disease Diseases 0.000 description 17
- 206010025421 Macule Diseases 0.000 description 13
- 208000002193 Pain Diseases 0.000 description 12
- 206010047642 Vitiligo Diseases 0.000 description 12
- 230000007812 deficiency Effects 0.000 description 8
- 210000002216 heart Anatomy 0.000 description 7
- 230000017531 blood circulation Effects 0.000 description 6
- 235000009508 confectionery Nutrition 0.000 description 6
- 230000001737 promoting effect Effects 0.000 description 6
- 239000002994 raw material Substances 0.000 description 6
- 206010040882 skin lesion Diseases 0.000 description 6
- 231100000444 skin lesion Toxicity 0.000 description 6
- 210000000952 spleen Anatomy 0.000 description 6
- 238000005303 weighing Methods 0.000 description 6
- 208000003251 Pruritus Diseases 0.000 description 5
- 239000012567 medical material Substances 0.000 description 5
- 230000008961 swelling Effects 0.000 description 5
- 208000008035 Back Pain Diseases 0.000 description 4
- 208000008930 Low Back Pain Diseases 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 208000002173 dizziness Diseases 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 201000000736 Amenorrhea Diseases 0.000 description 3
- 206010001928 Amenorrhoea Diseases 0.000 description 3
- 206010007247 Carbuncle Diseases 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 3
- 206010010904 Convulsion Diseases 0.000 description 3
- 201000004624 Dermatitis Diseases 0.000 description 3
- 231100000540 amenorrhea Toxicity 0.000 description 3
- 208000010668 atopic eczema Diseases 0.000 description 3
- 239000007844 bleaching agent Substances 0.000 description 3
- 230000036461 convulsion Effects 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 208000001780 epistaxis Diseases 0.000 description 3
- 208000035861 hematochezia Diseases 0.000 description 3
- 230000036737 immune function Effects 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 201000005404 rubella Diseases 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- 241000201295 Euphrasia Species 0.000 description 2
- 208000010201 Exanthema Diseases 0.000 description 2
- 208000034507 Haematemesis Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 208000025747 Rheumatic disease Diseases 0.000 description 2
- 206010040943 Skin Ulcer Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 244000046101 Sophora japonica Species 0.000 description 2
- 235000010586 Sophora japonica Nutrition 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 235000019658 bitter taste Nutrition 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 238000003759 clinical diagnosis Methods 0.000 description 2
- 230000035614 depigmentation Effects 0.000 description 2
- 230000008034 disappearance Effects 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 201000005884 exanthem Diseases 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 230000003908 liver function Effects 0.000 description 2
- 201000007227 lymph node tuberculosis Diseases 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 206010025482 malaise Diseases 0.000 description 2
- 201000004792 malaria Diseases 0.000 description 2
- 230000004630 mental health Effects 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 210000004877 mucosa Anatomy 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 208000037920 primary disease Diseases 0.000 description 2
- 206010037844 rash Diseases 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000000552 rheumatic effect Effects 0.000 description 2
- 231100000019 skin ulcer Toxicity 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 230000008736 traumatic injury Effects 0.000 description 2
- 210000003932 urinary bladder Anatomy 0.000 description 2
- 230000002087 whitening effect Effects 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 241001521511 Albizia kalkora Species 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 240000002930 Alternanthera sessilis Species 0.000 description 1
- 235000015579 Alternanthera sessilis Nutrition 0.000 description 1
- 241000331777 Arisaema balansae Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- AEMOLEFTQBMNLQ-AQKNRBDQSA-N D-glucopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-AQKNRBDQSA-N 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 208000034826 Genetic Predisposition to Disease Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010020850 Hyperthyroidism Diseases 0.000 description 1
- 241001313288 Labia Species 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 241000207923 Lamiaceae Species 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- 206010024380 Leukoderma Diseases 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 206010037549 Purpura Diseases 0.000 description 1
- 241001672981 Purpura Species 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 244000196426 Typhonium divaricatum Species 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 206010047799 Vulvovaginitis trichomonal Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 230000001919 adrenal effect Effects 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000002605 anti-dotal effect Effects 0.000 description 1
- 230000001363 autoimmune Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 235000019636 bitter flavor Nutrition 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 229940121657 clinical drug Drugs 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000009429 distress Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 244000309146 drought grass Species 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 239000007941 film coated tablet Substances 0.000 description 1
- 210000004905 finger nail Anatomy 0.000 description 1
- 210000003953 foreskin Anatomy 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 125000001475 halogen functional group Chemical group 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000036074 healthy skin Effects 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 239000010985 leather Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 208000013433 lightheadedness Diseases 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 210000003899 penis Anatomy 0.000 description 1
- RLLPVAHGXHCWKJ-UHFFFAOYSA-N permethrin Chemical compound CC1(C)C(C=C(Cl)Cl)C1C(=O)OCC1=CC=CC(OC=2C=CC=CC=2)=C1 RLLPVAHGXHCWKJ-UHFFFAOYSA-N 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 235000002378 plant sterols Nutrition 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 206010036596 premature ejaculation Diseases 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000009666 routine test Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000007940 sugar coated tablet Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 239000004577 thatch Substances 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 229940098465 tincture Drugs 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 210000003905 vulva Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及一种治疗白癜风的中成药,该中成药是将旱莲草、白芷、当归、何首乌、沙蒺藜、川穹、刺蒺藜、女贞子、荆芥、紫草、重楼、防风、藏红花、紫丹参、苦参、补骨脂。按照常规制药方法制成各种口服剂型。本发明具有温补肝肾、祛风除湿、调和气血、通经活络、活血化瘀、调节免疫功能,改善皮肤微循环的功效,对治疗和预防白癜风具有疗效确切,服用方便的特点。
Description
技术领域
本发明涉及皮肤类疾病的治疗技术领域,尤其涉及一种治疗白癜风疾病的中药技术领域。
背景技术
白癜风是一种常见的后天性、局限性的色素脱失性皮肤病,可发生于任何年龄,多见于儿童和青年。病损为大小不等的局限性脱色斑,边缘清楚,周围与健康皮肤交界处,皮色较浓;新发生损害周围常见有暂时性炎性晕轮、数目或单发或多发,可相互融合成片,患处毛发可变白,无任何自觉症状,日晒后损害部位有灼痒感。本病与多种自身免疫性疾病有关,如某些白癜风患者或其亲属,可合并有甲状腺功能亢进和减退、糖尿病等;某些患者的血液中发现甲状腺、胃、肾上腺组织的器官特异性抗体存在。本病常有家族史、具有家庭遗传倾向。此外,与体内铜、锌离子含量减低有关。患者多伴有汗液增多,表现温度增高,出血时间延长等症,作为白癜风疾病发生的原因多属于血虚血瘀受风者。
目前,治疗该病的方法和药物很多,但不能达到理想的效果,例如“激光”、“植皮”、“冷冻”等治疗方法,不仅疗效差,还给皮肤留下伤痕;有些药物如成药:消斑丸、去白素、白斑酊等,这些药物存在见效慢、疗程长,治愈率低和复发率高等缺点,有的药物还有过敏和轻微的中毒反应,也有的药物易引起肝、肾、脾肿大等副作用,给患者带来痛苦。
发明内容
本发明所要解决的技术问题是提供一种以消除患者的疾患,促进身心健康,同时具有患者服药方便、疗效快、无副作用的治疗白癜风的中药。
为解决上述技术问题,本发明是采用如下技术方案的:一种治疗白癜风的中药,其特殊之处是由下述重量配比的药物制成:旱莲草30-60份、白芷30-60份、当归10-30份、何首乌30-60份、沙蒺藜30-60份、川穹15-45份、刺蒺藜30-60份、女贞子10-30份、荆芥10-30份、紫草15-45份、重楼10-30份、防风10-30份、藏红花1-2份、紫丹参10-30份、苦参10-30份、补骨脂30-50份。
为进一步解决上述技术问题,本发明所述的治疗白癜风的中药的上述重量配比的药物,其优选方案为:旱莲草40-50份、白芷40-50份、当归15-25份、何首乌40-50份、沙蒺藜40-50份、川穹25-35份、刺蒺藜40-50份、女贞子15-25份、荆芥15-25份、紫草25-35份、重楼15-25份、防风15-25份、藏红花1.2-1.8份、紫丹参15-25份、苦参15-25份、补骨脂35-45份。
为进一步解决上述技术问题,本发明所述的治疗白癜风的中药的上述重量配比的药物,其最佳方案为:旱莲草45份、白芷45份、当归20份、何首乌45份、沙蒺藜45份、川穹30份、刺蒺藜45份、女贞子20份、荆芥20份、紫草30份、重楼20份、防风20份、藏红花1.5份、紫丹参20份、苦参20份、补骨脂40份。
上述所述的中药按照中药常规制备技术制成丸剂、丹剂、散剂、片剂、膏剂、汤剂及胶囊装粉剂不同的内服药剂型。
上述所述的中药还含有药物赋形剂。
本发明所述的中药的组方原则是:滋补肝脾、益气健脾、养血活血、通经活络、活血化瘀、扶正驱邪,调节免疫功能,改善皮肤微循环,达到治疗白癜风的目的。本发明具有药物配伍得当、组方合理,其所述各味药物的功效为:
旱莲草:别名:金陵草、莲子草、旱莲子、白旱莲、猪牙草、旱莲蓬等;味甘、酸、性凉;归肝、肾经,具有补益肝肾;凉血止血之功效;主肝肾不足、头晕目眩、须发早白、吐血、咯血、衄血、便血、血痢、崩、漏、外伤出血等症。
白芷:味辛,性温。入肺、胃经。白芷的功效,祛风解表,止痛,消肿排脓,燥湿止带。
当归:味甘辛、微苦、性温,归肝脾心经,有补血活血他、调经止痛之功效,本品与川穹配伍可以养血行滞、调经止痛等症;
何首乌:甘苦、涩,性微温,归肝、肾经,具有养血滋阴、润肠通便、截疟、祛风、解毒的功效。主治血虚头昏目眩、心悸、失眠、肝肾阴虚之腰膝酸弱;须发早白、耳鸣、遗精、肠燥便秘;久疟体虚;风疹瘙痒、疮痈、瘰疬、痔疮等疾病。
沙蒺藜:又名:沙苑子。为豆科植物扁茎黄芪的成熟种子。根据不同炮制方法分为沙苑蒺藜、盐沙蒺藜、炒沙苑蒺藜,炮制后贮干燥容器内,密闭,置通风干燥之处。性温、味甘、微苦,归肝、肾经,质润性和;具有温补肝肾,固精,缩尿,明目之功效。用于肾虚腰痛,遗精早泄,白浊带下,小便余沥,眩晕目昏等症。
川穹:味辛、性温,有行气活血、祛风止痛的作用,用于治疗月经不调、经闭痛经、癓瘕腹痛、胸肋刺痛、跌打肿痛、头痛、风湿痹痛等症;
刺蒺藜:别名、茨、蒺藜、蒺藜子、白蒺藜子、社蒺藜土蒺藜、白蒺藜、旱草、三角蒺藜、三角刺、八角刺、蒺骨子、野菱角、菱角刺等;味苦;辛;性平;归肝、肺、肾、心经;功效:平肝、解郁、祛风明目;主治头痛、眩晕、胸胁胀痛、乳房胀痛、乳闭不通、经闭、目赤翳障、风疹瘙痒、白癜风、疮疽、瘰疬等症。
女贞子:味甘苦、性微寒、归肝肾经,具有滋补肝肾,乌发明目之功效,本品入走肝肾能益精血、乌须发、平阴火、退虚热,常用于治疗肝肾不足而致疾病;
荆芥:味辛、性微温、归肺、肝经,具有解表散风、透疹、消疮、止血的功效,常用于治疗感冒、麻疹透发不畅、便血、崩漏、鼻衄等疾病。
紫草:性寒、味苦,甘、平,归入心、肝经。功效:凉血,活血,清热,解毒。主治温热斑疹,湿热黄疸,紫癜,吐、衄、尿血,淋浊,热结便秘,烧伤,湿疹,丹毒,痈疡等症。
重楼:别名:滇重楼、草河车、独脚莲。性状:根茎类圆柱形,多较平直,少数弯曲。直径1~6cm,长4.5~12cm。表面黄棕色,少数灰褐色,较平滑;性微寒,味苦;有小毒。功能主治:清热解毒,消肿止痛,凉肝定惊。作于疔肿痈肿、咽喉肿痛、毒蛇咬伤、跌扑伤痛、惊风抽搐。
防风:味辛、甘、性微温、归膀胱、肝、脾经,具有祛风解表、胜湿止痛、止痉之功效,用于治疗外感表证、风疹瘙痒、风湿痹痛、破伤风等疾病。
藏红花:味甘、性平,具有活血化瘀、散郁开结的功效。常用于治疗胸膈痞闷、吐血、伤寒发狂、惊怖恍惚、妇女经闭,产后瘀血腹痛、跌打肿痛等疾病。
紫丹参:又名丹参、赤参,紫丹参,红根等。为双子叶植物唇形科,干燥根及根茎。主产于安徽、河南、陕西等地。因其根较《中华人民共和国药典》收载的丹参.小,又主要产销云南,故又称紫丹参,味微苦,性微寒。色赤,入心经;具有补心,生血,养心,定志,安神宁心,健忘怔忡,惊悸不寐,生新血,去瘀血,安生胎,落死胎。一味可抵四物汤补血之功”。
苦参:别名:野槐、好汉枝、苦骨、地骨、地槐、山槐子;性寒、味苦,归心、肝、胃、大肠、膀胱经;功效:清热燥湿,杀虫,利尿。主治:用于热痢,便血,黄疸尿闭,赤白带下,阴肿阴痒,湿疹,湿疮,皮肤瘙痒,疥癣麻风;外治滴虫性阴道炎。
补骨脂:味辛、性温、无毒,具有滋阴补肾之功效,常用于元阳衰损、五劳七伤、肾虚腰痛、肾气虚寒、精气不固、遗尿、脾肾虚泻、水泻久痢、妊妇腰痛、跌坠腰痛、瘀血凝滞等病症;
本发明遵循中医“君臣佐使”的组方原则,全部成分来自于中国《药典》第五版收载的药物,诸药相和共具有温补肝肾,散风除湿,调和气血,通经活络、活血化瘀、扶正驱邪,调节免疫功能,改善皮肤微循环,促进皮肤色素生成,消白润肤的功效,治疗和预防白癜风、疗效确切,无毒副作用,各种中药制剂服用方便。
本发明药物临床使用结果表明,具有如下优点:
1、本发明选用的中药各组份符合中华人民共和国药品管理法之规定,利用各味中药的综合作用治疗和预防白癜风,对人体无毒无害。经小白鼠和大白鼠的急性毒性试验和蓄积性毒性试验表明被试验的动物未见任何毒性反应,经解剖观察血象、肝功能、各脏器组织形态学所见与对照组比较无差异,证明其药物安全可靠。
2、本发明所述的中药制剂无须煎煮、无苦涩感,药品中富含蛋白质、葡萄糖、葡萄糖醛酸、挥发油、果胶、果糖、有机酸、卵磷脂、维生素、氨基酸,还含皂甙、植物甾醇、钙等多种微量元素,有利于人体吸收,增强体质,且服用方便。
3、本发明所述的中药制剂不仅可有效的治疗白癜风,而且对白癜风的预防作用也非常明显,特别是通过药物之间的相互协同,增强药物各自治疗特性,通过通经活络和调节免疫功能,提高了患者身体内在的正气和身心健康及生存质量,较好的达到治愈康复效果。
下面通过临床应用例进一步说明本发明药物对治疗白癜风的治疗效果。
一、临床诊断标准:
白癜风的临床表现为:全身任何部门的皮肤均可发生,但始发于易阳光照射及磨擦损伤部,如颜面部、颈部、躯干部和四肢、口唇、阴唇、龟头及包皮内侧粘膜亦可累及。大部分白色斑对称分布,亦有部分患者白斑沿神经节段分布。皮损为局部性色素脱失斑、乳白色、自指甲至钱币大小,圆形、椭圆形或不规则形。白斑处毛发也可变白。在进展期,脱色斑向正常皮肤移行,发展较快,并有同形反应,即压力、摩擦、外伤后可形成继发白癜风。
根据皮肤白斑范围和分布可分三种类型:
1、局限性:皮损局限于一个部位,又可分为:(1)节段型:皮损按皮节分布;(2)粘膜型:仅累及粘膜。
2、泛发型:最常见,表现为皮损广泛分布于体表,可分为:
(1)寻常型:皮损散在分布于体表多处;
(2)面肢端型:皮损分布于面部和肢体远端;
(3)混合型:上述几种不同组合而成,如面肢端型+节段型等。
3、全身型:全身皮肤完全或几乎全部脱色,亦有毛发变白。
二、病例的选择
白癜风的发病率随地区、人种肤色而异,一般肤色越深的人发病率越高。我国人群中患病率约在0.1-2%,男女比例大致相等,从初生婴儿到老年均可发病,但以青少年为多。据有关资料记载:发病年龄在10-30岁内居多,占总数的62.65%,女性发病年龄较男性提早5年左右。为此,病例的选择以门疹就诊患者为全部病例。
三、疗效判定标准
在目前没有正式国家颁布的疗效判定标准之前,本发明采用的白癜风疗效判定标准(陈勤主编《中药美容保健品的研究与开发》中国医药科技出版社1999年版第228页)为:
(1)痊愈:白斑完全消失,皮肤组织病理学检查正常;
(2)显效:白斑50%以上消失,白斑消失部分组织病理学检查正常;
(3)有效:白斑消失者占原白斑面积的20-50%,或在白斑内见有较多色素岛;
(4)无效:治疗前后无变化或白斑扩大。
四、临床用药方法和治疗结果
1、临床用药方法
根据患者患病时间、病因及白斑范围和分布情况,分量用药:
服用实施例3的胶囊剂,每次3-7克,每日2-3次,温开水送服,饭前半小时服用。两个月为一个疗程,连续服用三个疗程观察疗效。
2、治疗结果
经临床诊断治疗白癜风患者共计89例,男性36例,女性53例,年龄为12-50岁。89例患者中痊愈58例占65.2%,显效23例占25.8%,有效6例占7%,无效2例占2%,总有效率达98%。经过治疗后,患者皮肤白斑不同程度消退或痊愈,且病人无任何不良反应,三大常规化验及肝肾功能检测未发现任何异常。经患者痊愈回访统计,至今未见一例复发。
具体实施方式
实施例1
按下列重量份称取各中药材:旱莲草30份、白芷30份、当归10份、何首乌30份、沙蒺藜30份、川穹15份、刺蒺藜30份、女贞子10份、荆芥10份、紫草15份、重楼10份、防风10份、藏红花1份、紫丹参10份、苦参10份、补骨脂30份。
本实施例的制备工艺为:将上述各药材原料按照常规制备丹剂的制药方法制成丹剂。
实施例2
按下列重量份称取各药材:旱莲草60份、白芷60份、当归30份、何首乌60份、沙蒺藜60份、川穹45份、刺蒺藜60份、女贞子30份、荆芥30份、紫草45份、重楼30份、防风30份、藏红花2份、紫丹参30份、苦参30份、补骨脂50份。
本实施例的制备工艺为:将上述各药材原料按照常规制备散剂的制药方法制成袋装散剂。
实施例3
按下列重量份称取各药材:旱莲草40份、白芷40份、当归15份、何首乌40份、沙蒺藜40份、川穹25份、刺蒺藜40份、女贞子15份、荆芥15份、紫草25份、重楼15份、防风15份、藏红花1.2份、紫丹参15份、苦参15份、补骨脂35份。
本实施例的制备工艺为:将上述各药材原料按照常规制备胶囊剂的制药方法制成胶囊剂。
实施例4
按下列重量份称取各药材:旱莲草50份、白芷50份、当归25份、何首乌50份、沙蒺藜50份、川穹35份、刺蒺藜50份、女贞子25份、荆芥25份、紫草35份、重楼25份、防风25份、藏红花1.8份、紫丹参25份、苦参25份、补骨脂45份。
本实施例的制备工艺为:将上述各药材原料按照常规制备片剂的制药方法制成片剂,(如普通片剂、糖衣片剂、薄膜衣片剂等),并赋予常规的药物赋形剂(如淀粉、蔗糖、乳糖、硬脂酸钙、硬脂酸镁等)。
实施例5
按下列重量份称取各药材:旱莲草45份、白芷45份、当归20份、何首乌45份、沙蒺藜45份、川穹30份、刺蒺藜45份、女贞子20份、荆芥20份、紫草30份、重楼20份、防风20份、藏红花1.5份、紫丹参20份、苦参20份、补骨脂40份。
本实施例的制备工艺为:将上述各药材原料按照常规制备丸剂的制药方法制成丸剂,并赋予常规的药物赋形剂。
实施例6
按下列重量份称取各药材:旱莲草42份、白芷42份、当归20份、何首乌42份、沙蒺藜42份、川穹30份、刺蒺藜42份、女贞子22份、荆芥22份、紫草30份、重楼22份、防风22份、藏红花1.5份、紫丹参22份、苦参22份、补骨脂40份。
本实施例的制备工艺为:将上述各药材原料按照常规制备颗粒剂的制药方法制成颗粒剂。
Claims (5)
1.一种治疗白癜风的中药,其特征是由下述重量配比的药物制成:旱莲草30-60份、白芷30-60份、当归10-30份、何首乌30-60份、沙蒺藜30-60份、川穹15-45份、刺蒺藜30-60份、女贞子10-30份、荆芥10-30份、紫草15-45份、重楼10-30份、防风10-30份、藏红花1-2份、紫丹参10-30份、苦参10-30份、补骨脂30-50份。
2.根据权利要求1所述的治疗白癜风的中药,其特征是由下述重量配比的药物制成;旱莲草40-50份、白芷40-50份、当归15-25份、何首乌40-50份、沙蒺藜40-50份、川穹25-35份、刺蒺藜40-50份、女贞子15-25份、荆芥15-25份、紫草25-35份、重楼15-25份、防风15-25份、藏红花1.2-1.8份、紫丹参15-25份、苦参15-25份、补骨脂35-45份。
3.根据权利要求1所述的治疗白癜风的中药,其特征是由下述重量配比的药物制成:旱莲草45份、白芷45份、当归20份、何首乌45份、沙蒺藜45份、川穹30份、刺蒺藜45份、女贞子20份、荆芥20份、紫草30份、重楼20份、防风20份、藏红花1.5份、紫丹参20份、苦参20份、补骨脂40份。
4.根据权利要求1至3中任一权利要求所述的治疗白癜风的中药,其特征是所述的中成药按照中药常规制备技术制成丸剂、丹剂、散剂、片剂、膏剂、汤剂及胶囊装粉剂不同的内服药剂型。
5.根据权利要求4所述的治疗白癜风的中药,其特征是所述的中成药还含有药物赋形剂。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2011101698286A CN102362950A (zh) | 2011-06-15 | 2011-06-15 | 一种治疗白癜风的中药 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2011101698286A CN102362950A (zh) | 2011-06-15 | 2011-06-15 | 一种治疗白癜风的中药 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN102362950A true CN102362950A (zh) | 2012-02-29 |
Family
ID=45689566
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2011101698286A Pending CN102362950A (zh) | 2011-06-15 | 2011-06-15 | 一种治疗白癜风的中药 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102362950A (zh) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103393903A (zh) * | 2013-08-06 | 2013-11-20 | 董云 | 一种治疗白癜风的药物 |
CN103705605A (zh) * | 2013-12-16 | 2014-04-09 | 崔夕军 | 一种治疗白癜风的中药 |
CN103720821A (zh) * | 2014-01-24 | 2014-04-16 | 王兰玲 | 一种治疗白癜风的外用药膏及制备方法 |
CN103860930A (zh) * | 2014-03-19 | 2014-06-18 | 李常明 | 一种有效治疗白癜风的中药组合物 |
CN105147954A (zh) * | 2015-09-29 | 2015-12-16 | 成都倍加特生物科技有限公司 | 一种治疗白癜风的散剂药物及其制备方法 |
CN105194227A (zh) * | 2015-10-30 | 2015-12-30 | 吴小斌 | 一种治疗白癜风的中药丸及其制备方法 |
CN105250476A (zh) * | 2015-11-13 | 2016-01-20 | 何江思 | 一种用于治疗白癜风的贴剂及其用法 |
CN106038939A (zh) * | 2016-07-25 | 2016-10-26 | 陈凯 | 一种治疗白癜风的中药 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1273847A (zh) * | 1999-05-14 | 2000-11-22 | 王志明 | 用于治疗皮肤病的中药 |
-
2011
- 2011-06-15 CN CN2011101698286A patent/CN102362950A/zh active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1273847A (zh) * | 1999-05-14 | 2000-11-22 | 王志明 | 用于治疗皮肤病的中药 |
Non-Patent Citations (1)
Title |
---|
乔桂华等主编: "《中医辨证施治皮肤科疑难病》", 30 November 2006, article "第十二章色素障碍性皮肤病", pages: 310-311 * |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103393903A (zh) * | 2013-08-06 | 2013-11-20 | 董云 | 一种治疗白癜风的药物 |
CN103393903B (zh) * | 2013-08-06 | 2015-02-25 | 董云 | 一种治疗白癜风的药物 |
CN103705605A (zh) * | 2013-12-16 | 2014-04-09 | 崔夕军 | 一种治疗白癜风的中药 |
CN103720821A (zh) * | 2014-01-24 | 2014-04-16 | 王兰玲 | 一种治疗白癜风的外用药膏及制备方法 |
CN103720821B (zh) * | 2014-01-24 | 2015-08-19 | 王兰玲 | 一种治疗白癜风的外用药膏及制备方法 |
CN103860930A (zh) * | 2014-03-19 | 2014-06-18 | 李常明 | 一种有效治疗白癜风的中药组合物 |
CN103860930B (zh) * | 2014-03-19 | 2016-06-01 | 刘凤伟 | 一种有效治疗白癜风的中药组合物 |
CN105147954A (zh) * | 2015-09-29 | 2015-12-16 | 成都倍加特生物科技有限公司 | 一种治疗白癜风的散剂药物及其制备方法 |
CN105194227A (zh) * | 2015-10-30 | 2015-12-30 | 吴小斌 | 一种治疗白癜风的中药丸及其制备方法 |
CN105250476A (zh) * | 2015-11-13 | 2016-01-20 | 何江思 | 一种用于治疗白癜风的贴剂及其用法 |
CN106038939A (zh) * | 2016-07-25 | 2016-10-26 | 陈凯 | 一种治疗白癜风的中药 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102416079A (zh) | 一种治疗白癜风的中成药 | |
CN103251867A (zh) | 一种治疗糖尿病的中药复方药物及其制备方法 | |
CN102362950A (zh) | 一种治疗白癜风的中药 | |
CN103520572A (zh) | 一种用于治疗特应性皮炎的中药组合物及其制备方法 | |
CN100496585C (zh) | 一种治疗黄褐斑的中药制剂 | |
CN104958607A (zh) | 一种治疗妇女更年期灼口综合征的中药组合物及方法 | |
CN101912551B (zh) | 一种安胎中药组合物 | |
CN103432559A (zh) | 一种治疗血滞型月经减少及痛经的中药组合物及其制备方法和用途 | |
CN101897933B (zh) | 一种治疗白癜风的中成药 | |
CN102178781B (zh) | 一种治疗阴囊湿疹的中药组合物及其制备方法 | |
CN102430013A (zh) | 治疗白癜风的中药 | |
CN104383257A (zh) | 一种治疗肝郁阴虚型干眼症的中药制剂 | |
CN102430097A (zh) | 一种治疗白癜风的中药 | |
CN102727648A (zh) | 一种治疗白癜风的中药组合物 | |
CN104784538B (zh) | 一种治疗糖尿病的中药制剂及制备方法 | |
CN103977281A (zh) | 一种治疗女性内分泌失调的中药组合物及其制备方法 | |
CN102423433A (zh) | 一种用于治疗银屑病的中药混合物 | |
CN104906430A (zh) | 一种治疗干眼症的中药制剂及其制备方法 | |
CN102406865A (zh) | 一种治疗银屑病的中药组合物 | |
CN103690869B (zh) | 治疗肠易激综合征的中药及其制备方法 | |
CN102406893A (zh) | 一种治疗银屑病的中成药 | |
CN102579895B (zh) | 一种治疗银屑病的中药组合物 | |
CN105169189A (zh) | 一种治疗甲减的药物 | |
CN104288581A (zh) | 用于治疗先兆流产的中药 | |
CN104042944A (zh) | 用于治疗黄褐斑的药物制剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20120229 |